Norwegian University of Life Sciences Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Aas Norway (1859)

Organization Overview

First Clinical Trial
2009
NCT04298333
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Ågot Aakra | NHH-Norwegian School of Economics | NORCE Norwegian Research Centre AS | Norwegian University of Life Sciences | Norwegian University of Science and Technology Faculty of Medicine and Health Sciences Department of Public Health and Nursing | Norwegian Women's Public Health Association (Norske Kvinners Sanitetsforening) | Prof Stig Larsen | Skjetten Legesenter | Tine

Active Ingredients

Drugs in Phase 4 Trials (3)

doxycycline (vibramycin) (1 trial)

phenoxymethylpenicillin (1 trial)

procaine benzylpenicillin (novocaine) (1 trial)

Drugs in Phase 2 Trials (2)

bp-c1 (5 trials)

bp-c2 (2 trials)

Drugs in Other Trials (5)

butter (1 trial)

egg (1 trial)

gamalost (1 trial)

gouda cheese (1 trial)

iron (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Erythema (Phase 4)

Erythema Chronicum Migrans (Phase 4)

Glossitis, Benign Migratory (Phase 4)

Lyme Disease (Phase 4)

Prostatic Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 11
  • # of Trial APIs: 10